This special section focuses on up-and-coming developments in the field of bioengineering. Articles review biological information storage, genetically engineered probiotics, and next-generation cancer detection methodologies.
Gopal Karemore is a director at the digital research & intelligence wing of Novo Nordisk A/S in Denmark. He has PhD in computer science from Univ. of Copenhagen with 14+ years of experience in data science, statistics, modelling, machine learning, visualisation, and quantum computing within early research, preclinical, and clinical pharmaceutical settings. He co-authored 35+ research articles published in high-impact scientific journals, e.g. Nature, iScience, IEEE, and was involved in shaping strategic initiatives and business development within pharmaceutical R&D processes....Read more
Jasmine Rowe is a Director in Oral Formulation Sciences at Merck, where she is responsible for drug product development for the advancement of Merck’s oral small-molecule pipeline. Within her role, she is also leading systemic efforts to advance pediatric formulation development and amorphous solid dispersion technology development. Prior to Merck, she supported drug product development at Bristol Myers Squibb for ~10 years, holding roles in Oral Drug Product Development and Engineering Technologies, which focused on progressing the implementation of small-scale tools and models to drive...Read more
Vicente is a PhD graduate from the University of Southern California, currently a senior scientist working on high temperature fuel cells at Advent Technologies. He has worked with a myriad of electrochemical systems, including various types of fuel cells, electrochemical synthesis of materials and carbon dioxide reduction.Read more
